Ratings
0
Nobody has rated this yet. Be the first!
Works
2
Potential Barriers to Clinical Trials of New Therapeutics for Myelodysplastic Syndromes: Wide Variation in Risk Definitions and Trial Enrollment Criteria
In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs
